BRIEF-Atossa Therapeutics says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC Filing

Reuters
08 Apr
BRIEF-Atossa <a href="https://laohu8.com/S/LENZ">Therapeutics</a> says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC Filing

April 7 (Reuters) - Atossa Therapeutics Inc ATOS.O:

  • ATOSSA THERAPEUTICS INC - INTAS PHARMACEUTICALS FILES PETITION FOR POST GRANT REVIEW AGAINST CO- SEC FILING

  • ATOSSA THERAPEUTICS INC - INTAS PHARMACEUTICALS FILES PETITION FOR INTER PARTES REVIEW AGAINST CO

  • ATOSSA THERAPEUTICS INC - TO CONTEST PGR AND IPR PETITIONS - SEC FILING

Source text: [ID:n0000950170-25-051575]

Further company coverage: ATOS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10